Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Dyax and Debiopharm collaborate to develop treatments for pulmonary disorders

April 21, 1997

Alliance temporarily suspends enrollment in its LiquiVent clinical trial

April 21, 1997

Rhone-Poulenc Rorer's ebastine now available in The Netherlands

April 17, 1997

New cell adhesion inhibitor from Biogen

April 17, 1997

Dual TxA2/LT receptor antagonist selected for development by Yamanouchi

April 17, 1997

Biogen reveals new cell adhesion inhibitor

April 16, 1997

Schering-Plough's Nasonex approved in U.K. and France

April 15, 1997

Nasacort now available for the treatment of allergic rhinitis

April 15, 1997

ABT-761 reduces bronchoconstriction and pulmonary inflammation in animals

April 14, 1997

First CFC-free inhaler launched in U.S.

April 14, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...